Evidence map›Paper›PMID 37793617›Full record

ArticleApplied clinical informatics2023

Barriers to Adoption of Tailored Drug-Drug Interaction Clinical Decision Support.

Tianyi Zhang, Sheila M Gephart, Vignesh Subbian, Richard D Boyce, Lorenzo Villa-Zapata, Malinda S Tan, John Horn, Ainhoa Gomez-Lumbreras, Andrew V Romero, Daniel C Malone

Abstract read
In one paragraph

Article in Applied clinical informatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tianyi ZhangDepartment of Systems and Industrial Engineering, College of Engineering, University of Arizona, Tucson, Arizona.
Sheila M GephartAdvanced Nursing Practice and Science Division, College of Nursing, University of Arizona, Tucson, Arizona.
Vignesh SubbianDepartment of Systems and Industrial Engineering, College of Engineering, University of Arizona, Tucson, Arizona.
Richard D BoyceDepartment of Biomedical Informatics, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Lorenzo Villa-ZapataClinical and Administrative Pharmacy, College of Pharmacy, University of Georgia, Athens, Georgia.
Malinda S TanDepartment of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah.
John HornDepartment of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington.
Ainhoa Gomez-LumbrerasDepartment of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah.
Andrew V RomeroDepartment of Pharmacy, Tucson Medical Center, Tucson, Arizona.
Daniel C MaloneDepartment of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah.

Funding

Meaningful Drug Interaction AlertsR01HS025984 · AHRQ · UNIVERSITY OF UTAH · PI MALONE, DANIEL C · 2018 to 2021
$1.5M
AHRQ HHS R01 HS025984
6 · The paper itself

Abstract

objectiveDespite the benefits of the tailored drug-drug interaction (DDI) alerts and the broad dissemination strategy, the uptake of our tailored DDI alert algorithms that are enhanced with patient-specific and context-specific factors has been limited. The goal of the study was to examine barriers and health care system dynamics related to implementing tailored DDI alerts and identify the factors that would drive optimization and improvement of DDI alerts.

methodsWe employed a qualitative research approach, conducting interviews with a participant interview guide framed based on Proctor's taxonomy of implementation outcomes and informed by the Theoretical Domains Framework. Participants included pharmacists with informatics roles within hospitals, chief medical informatics officers, and associate medical informatics directors/officers. Our data analysis was informed by the technique used in grounded theory analysis, and the reporting of open coding results was based on a modified version of the Safety-Related Electronic Health Record Research Reporting Framework.

resultsOur analysis generated 15 barriers, and we mapped the interconnections of these barriers, which clustered around three entities (i.e., users, organizations, and technical stakeholders). Our findings revealed that misaligned interests regarding DDI alert performance and misaligned expectations regarding DDI alert optimizations among these entities within health care organizations could result in system inertia in implementing tailored DDI alerts.

conclusionHealth care organizations primarily determine the implementation and optimization of DDI alerts, and it is essential to identify and demonstrate value metrics that health care organizations prioritize to enable tailored DDI alert implementation. This could be achieved via a multifaceted approach, such as partnering with health care organizations that have the capacity to adopt tailored DDI alerts and identifying specialists who know users' needs, liaise with organizations and vendors, and facilitate technical stakeholders' work. In the future, researchers can adopt the systematic approach to study tailored DDI implementation problems from other system perspectives (e.g., the vendors' system).

Indexed as

Decision Support Systems, ClinicalMedical Order Entry SystemsDrug InteractionsElectronic Health RecordsHumansPharmacists

Identifiers

PMID37793617
PMCPMC10550365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.